The past two days have been an energizing dive into a paradigm shift: thinking about the future through a wellness lens rather than the traditional treatment angle. It’s a refreshing contrast to the discussions at the Riyadh Global Medical Biotechnology Summit Summit a few months ago, where Stephen Squinto (CIO, J.P. Morgan Life Sciences Private Capital) introduced the concept of the "death of death"—suggesting that in the future, the question may not be about biological aging but rather the decision to die.
While both discussions revolve around longevity, the approach at Hevolution was distinct. Extending Healthspan has profound economic implications—boosting productivity and wellness along with reducing the burden of disease (BoD), and lowering long-term medical costs.
𝗞𝗲𝘆 𝗧𝗮𝗸𝗲𝗮𝘄𝗮𝘆𝘀:
𝘓𝘰𝘯𝘨𝘦𝘷𝘪𝘵𝘺 𝘪𝘴 𝘯𝘰 𝘭𝘰𝘯𝘨𝘦𝘳 𝘢𝘯 𝘢𝘯𝘰𝘮𝘢𝘭𝘺 – 1 in 2 people today have a strong chance of living well into their 90s. That’s a massive mindset shift.
𝘛𝘩𝘦 𝘨𝘢𝘱 𝘪𝘯 𝘸𝘦𝘭𝘭𝘯𝘦𝘴𝘴 𝘥𝘢𝘵𝘢 – Our systems are built around sickness; we only collect health data when people seek treatment. How do we start capturing wellness data earlier and more comprehensively?
𝘚𝘺𝘴𝘵𝘦𝘮𝘪𝘤 𝘤𝘩𝘢𝘯𝘨𝘦 𝘪𝘴 𝘯𝘦𝘦𝘥𝘦𝘥 – Some nations are implementing long-term visions for longevity, but existing healthcare frameworks are becoming obsolete. Do we need a new system rather than incremental changes?
𝘍𝘪𝘯𝘢𝘯𝘤𝘪𝘢𝘭 𝘮𝘰𝘥𝘦𝘭𝘴 𝘮𝘶𝘴𝘵 𝘦𝘷𝘰𝘭𝘷𝘦 – If most young people today will live to 90+, we need innovative financial instruments to sustain them. Institutional investors aren’t fully prepared, and without public mechanisms to subsidize longevity-focused investments, adoption will be slow.
𝘞𝘦𝘭𝘭𝘯𝘦𝘴𝘴 𝘪𝘴 𝘢 𝘮𝘢𝘴𝘴𝘪𝘷𝘦 𝘤𝘰𝘯𝘴𝘶𝘮𝘦𝘳 𝘣𝘶𝘴𝘪𝘯𝘦𝘴𝘴 – The opportunity goes far beyond therapeutics. We need to shift from treating sickness to proactively improving healthspan for entire populations. This means setting a higher bar—both scientifically and economically.
𝘈𝘨𝘪𝘯𝘨 𝘳𝘦𝘴𝘦𝘢𝘳𝘤𝘩 𝘪𝘴 𝘯𝘰𝘸 𝘢𝘯 𝘦𝘤𝘰𝘯𝘰𝘮𝘪𝘤 𝘥𝘪𝘴𝘤𝘶𝘴𝘴𝘪𝘰𝘯 – It’s no longer just about science and biology; this conversation now spans economics, consumer behavior, and policy-making.
𝘗𝘩𝘪𝘭𝘢𝘯𝘵𝘩𝘳𝘰𝘱𝘺 𝘩𝘢𝘴 𝘢 𝘤𝘳𝘪𝘵𝘪𝘤𝘢𝘭 𝘳𝘰𝘭𝘦 – The King Faisal Foundation has already committed $260M to transformative health initiatives. What more can be done to catalyze long-term impact?
𝗢𝗻𝗲 𝗰𝗹𝗲𝗮𝗿 𝗺𝗲𝘀𝘀𝗮𝗴𝗲: 𝘊𝘰𝘭𝘭𝘢𝘣𝘰𝘳𝘢𝘵𝘪𝘰𝘯 𝘪𝘴 𝘬𝘦𝘺
Ensuring extended lifespans are spent meaningfully and ethically requires a multidisciplinary approach. The longevity revolution is here—how do we move from insight to action?
Comments